We have previously shown that TP53 wild-type breast cancer cells survive chemotherapy by entering a senescent state that arrests the cell cycle to prevent mitotic catastrophe [4,5] and blocks apoptosis by activity of BCL-XL and/or MCL1 [6,7]. This evidence concerns the gene TP53 and breast carcinoma.